Philippe P. Roux
Signalisation cellulaire et protéomique
- Professeur titulaire
-
Faculté de médecine - Département de pathologie et biologie cellulaire
Pavillon Marcelle-Coutu, room 1306-17
Profile
Research expertise
Les mécanismes de signalisation cellulaire sont essentiels pour que les cellules intègrent les signaux de l’environnement externe génèrent des réponses adaptées. La dérégulation de ces mécanismes par des mutations dans des protéines de signalisation entraînent diverses pathologies. L’un des exemples les plus létaux est le cancer, qui résulte souvent de mutations qui activent des proto-oncogènes (par exemple, KRAS, BRAF, PIK3CA) ou inactivent des gènes suppresseurs de tumeurs (par exemple, PTEN, APC, TP53). L’objectif principal du laboratoire Roux est de décoder les réseaux de signalisation au sein des cellules cancéreuses afin de faciliter le développement de nouveaux traitements anticancéreux
Awards and recognitions
- Chercheur-boursier sénior, Fonds de recherche du Québec - Santé (FRQS) 2016-2020
- Prix Nouveau scientifique GE Healthcare, 2013
- Chaire de recherche du Canada en signalisation cellulaire et protéomique, 2006-2016
- Bourse Développement de la carrière, Human Frontier Science Program, 2007-
- Boursier postdoctoral, Human Frontier Science Program, 2003-2006
- Boursier postdoctoral, Instituts de Recherche en Santé du Canada, 2002-2003
- Liste d’honneur du doyen, Faculté de Médecine, Université McGill, 2002
- Boursier doctoral, Instituts de Recherche en Santé du Canada, 1999-2002
- Boursier doctoral, Fondation Neuroscience Canada, 1998-1999
- Boursier doctoral, Fondation Jean Timmons Costello, 1997-1998
- Boursier à la maîtrise, Conseil des Services Sociaux du Québec, 1995-1997
education
- 2006 — Stage postdoctoral en biologie du cancer — Biologie cellulaire, Oncologie — Harvard Medical School
- 2002 — Ph.D. Neurosciences moléculaires — Neurosciences — Université McGill - Institut Neurologique de Montréal
- 1997 — M.Sc. Microbiologie et immunologie — Immunologie, Microbiologie — Université de Montréal - Centre de Recherche de l’Hôpital Sainte-Justine
- 1995 — B.Sc. Sciences biologiques — Immunologie, Microbiologie — Université de Montréal, Montréal
Affiliations and responsabilities
Research affiliations
Research units
Directeur scientifique
Teaching and supervision
Teaching
Courses taught (current session only)
Programs
Student supervision
Theses and dissertation supervision (Papyrus Institutional Repository)
Le rôle de MYC dans la sénescence induite par la thérapie des cellules du cancer épithélial de l’ovaire
Cycle : Master's
Grade : M. Sc.
Identification of copper metabolism as a KRAS-specific vulnerability in colorectal cancer
Cycle : Doctoral
Grade : Ph. D.
Analyse protéomique de la sénescence induite par la chimiothérapie dans le cancer de l'ovaire
Cycle : Master's
Grade : M. Sc.
Rôle du complexe NF45-NF90 dans la régulation post-transcriptionnelle du cycle cellulaire
Cycle : Doctoral
Grade : Ph. D.
Étude des kinases RSK : de l’interactome aux fonctions biologiques
Cycle : Doctoral
Grade : Ph. D.
Rôles non-canoniques des arrestines dans la signalisation et l’endocytose des récepteurs couplés aux protéines G
Cycle : Doctoral
Grade : Ph. D.
Characterization of p120-catenin, a novel RSK substrate in the Ras/MAPK signalling pathway.
Cycle : Master's
Grade : M. Sc.
Phosphorylation et régulation de l’E3 ubiquitine ligase MDM2 par la protéine kinase RSK dans les mélanomes
Cycle : Master's
Grade : M. Sc.
Understanding the role of CAP proteins in the polarization process of C. elegans
Cycle : Master's
Grade : M. Sc.
Régulation du métabolisme des ARNm par les voies de signalisation MAPK et mTOR
Cycle : Doctoral
Grade : Ph. D.
Feedback regulation of Gab2-dependent signaling by the Ras/MAPK pathway
Cycle : Doctoral
Grade : Ph. D.
Projects
Research projects
Targeting ENPP1-dependent immune evasion in ErbB2-positive breast cancer
Identification of MYC-dependent vulnerabilities in breast cancer
Live cell imaging platform for the mechanistic analysis of cell differentiation, migration and division
CECR_IRICoR_Therapeutic antibody development in acute myeloid leukemia
Engineered hematopoietic stem cells (eHSCs) as vehicles for next generation therapies
StemCell Nerwork - Réseau des cellules souches - Engineered hematopoietic stem cells (eHSCs) as vehicles for next generation therapies
Cellular reprogramming during cell cycle progression
Targeting CDK12 to overcome melanoma chemoresistance
Interrogating and implementing Omics for precision medicine in Acute Myeloid Leukemia.
A functional surfaceome map of human hematopoietic stem and progenitor cells
Identification of MYC-dependent vulnerabilities in breast cancer
Copper bioavailability as a new vulnerability in colorectal cancer
Interrogating and implementing Omics for precision medicine in Acute Myeloid Leukemia
The role of LARP1 in the translation of growth promoting mRNAs
Bioluminescence resonance energy transfer detection system for the monitoring of proteinprotein interactions, posttranslational modifications and cell signalling.
Interrogating and implementing Omics for precision medicine in Acute Myeloid Leukemia
Supplément COVID-19 CRSNG_Cellular reprogramming during cell cycle progression
Identification de nouveaux régulateurs de la voie Ras/MAPK à l'aide d'une nouvelle approche protéomique
Dual molecular functions of LMO2 as a master oncogene in T-cell acute lymphoblastic leukemia
Régulation oncogénique de la croissance cellulaire par la voie de signalisation mTOR
Targeting pre-leukemic stem cells in T acute lymphoblastic leukemia
UNE APPROCHE CHIMIO- ET PROTEO-GENOMIQUE EN MEDECINE PERSONNALISEE POUR LA LEUCEMIE MYELOIDE AIGUE
Control of hematopoietic cell fate by LMO2
Development of Companion Therapies for Poor Outcome HMGA2+ Acute Myeloid Leukemia
MAPK-DEPENDENT REGULATION OF GAB2 FUNCTION
IDENTIFICATION AND CHARACTERIZATION OF NOVEL RSK SUBSTRATES
ROLE OF CK1 IN TUMOUR GROWTH AND RESISTANCE
INTERPLAY BETWEEN MECHANICAL AND BIOLOGICAL MECHANISMS DURING CELL CORTEX ASSEMBLY - RENEWAL APPLICATION
EVALUATION OF RSK4 AS SENESCENCE-RELATED TUMOUR SUPRESSOR IN COLORECTAL CANCER
CHAIRE DE RECHERCHE DU CANADA : CELL SIGNALLING AND PROTEOMICS
MITOGENIC AND ONCOGENIC REGULATION OF RSK SIGNALING
REGULATION AND FUNCTION OF THE RSK FAMILY IN BREAST CANCER
Outreach
Publications and presentations
Publications
2024
The expanding landscape of canonical and non-canonical protein phosphorylation
Houles T, Yoon SO, Roux PP
Trends Biochem. Sci. 49, 986-999 (2024)
Immunotherapeutic targeting of surfaceome heterogeneity in AML
Bordeleau ME, Audemard E, Metois A, Theret L, Lisi V, Farah A, Spinella JF, Chagraoui J, Moujaber O, Aubert L, Khakipoor B, Mallinger L, Boivin I, Mayotte N, Hajmirza A, Bonneil E, Beliveau F, Pfammatter S, Feghaly A, Boucher G, Gendron P, Thibault P, Barabe F, Lemieux S, Richard-Carpentier G, Hebert J, Lavallee VP, Roux PP, Sauvageau G
Cell Rep. 43, 114260 (2024)
14-3-3 regulates adipogenesis by modulating chromatin accessibility during the early stages of adipocyte differentiation
Rial SA, You Z, Vivoli A, Sean D, Al-Khoury A, Lavoie G, Civelek M, Martinez-Sanchez A, Roux Pp, Durcan TM, Lim GE
bioRxiv (2024)
Plakoglobin regulates adipocyte differentiation independently of the Wnt/B-catenin signaling pathway
Abou Azar F, Mugabo Y, Yuen S, Del Veliz S, Pare F, Rial SA, Lavoie G, Roux PP, Lim GE
Biochim Biophys Acta Mol Cell Res. 1871, 119690 (2024)
Identification of RSK substrates using an analog-sensitive kinase approach
Lizcano-Perret B, Vertommen D, Herinckx G, Calabrese V, Gatto L, Roux PP, Michiels T
J Biol Chem. 300, 105739 (2024)
2023
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
Houles T, Boucher J, Lavoie G, MacLeod G, Lin S, Angers S, Roux PP
Cell Death Discov. 9, 459 (2023)
CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216
Gress V, Roussy M, Boulianne L, Bilodeau M, Cardin S, El-Hachem N, Lisi V, Khakipoor B, Rouette A, Farah A, Théret L, Aubert L, Fatima F, Audemard E, Thibault P, Bonneil E, Chagraoui J, Laramée L, Gendron P, Jouan L, Jammali S, Paré B, Simpson SM, Tran TH, Duval M, Teira P, Bittencourt H, Santiago R, Barabé F, Sauvageau G, Smith MA, Hébert J, Roux PP, Gruber TA, Lavallée VP, Wilhelm BT, Cellot S
Blood Adv. Sep 20, Online ahead of print (2023)
HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
Attalla SS, Boucher J, Proud H, Taifour T, Zuo D, Sanguin-Gendreau V, Ling C, Johnson G, Li V, Luo RB, Kuasne H, Papavasiliou V, Walsh LA, Barok M, Joensuu H, Park M, Roux PP, Muller WJ
Cancer Immunol. Res. 11, 1184-1202 (2023)
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
Dervovic D, Malik AA, Chen ELY, Narimatsu M, Adler N, Afiuni-Zadeh S, Krenbek D, Martinez S, Tsai R, Boucher J, Berman JM, Teng K, Ayyaz A, Lu Y, Mbamalu G, Loganathan SK, Lee J, Zhang L, Guidos C, Wrana J, Valipour A, Roux PP, Reimand J, Jackson HW, Schramek D.
Nature Commun. 14, 3150 (2023)
2022
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
Houles T, Lavoie G, Nourreddine S, Cheung W, Vaillancourt-Jean E, Guerin CM, Bouttier M, Grondin B, Lin S, Saba-El-Leil MK, Angers S, Meloche S, Roux PP
Nature Commun. 13, 6457 (2022)
Proteomic analysis of the actin cortex in interphase and mitosis
Vadnjal N, Nourreddine S, Lavoie G, Serres M, Roux PP, Paluch EK
J. Cell Sci. 135, jcs259993 (2022)
Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
Heckel E, Cagnone G, Agnihotri T, Cakir B, Das A, Kim JS, Kim N, Lavoie G, Situ A, Pundir S, Sun Y, Wunnemann F, Pierce KA, Dennis C, Mitchell GA, Chemtob S, Rezende FA, Andelfinger G, Clish CB, Roux PP, Sapieha P, Smith LE, Joyal JS
JCI Insight 7, e154174 (2022)
CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells
Ansari U, Tomellini E, Chagraoui J, Lehnertz B, Mayotte N, Bordeleau ME, Roux PP, Sauvageau G
Blood Adv. 6, 3626-3631 (2022)
2021
RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
Cerezo EL, Houles T, Lie O, Sarthou MK, Audoynaud C, Lavoie G, Halladjian M, Cantaloube S, Froment C, Burlet-Schiltz O, Henry Y, Roux PP, Henras AK, Romeo Y
PLoS Genet. 17, e1009583 (2021)
Sustained ERK1/2 signaling is necessary for follicular rupture during ovulation in mice
Madogwe E, Schuermann Y, Siddappa D, Bordignon V, Roux PP, Duggavathi R
Reproduction 161, 183-193 (2021)
2020
Targeting copper metabolism to defeat KRAS-driven colorectal cancer
Aubert L, Nandagopal N, Roux PP
Mol. Cell. Oncol. 7, 1822123 (2020)
STRIPAK regulates Slik localization to control mitotic morphogenesis and epithelial integrity
De Jamblinne CV, Decelle B, Dehghani M, Joseph M, Sriskandarajah N, Leguay K, Rambaud B, Lemieux S, Roux PP, Hipfner DR, Carreno S
J. Cell Biol. 219, e201911035 (2020)
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
Aubert L, Nandagopal N, Steinhart Z, Lavoie G, Nourreddine S, Berman J, Saba-El-Leil MK, Papadopoli D, Lin S, Hart T, Macleod G, Topisirovic I, Gaboury L, Fahrni CJ, Schramek D, Meloche S, Angers S, Roux PP
Nature Commun. 11, 3701 (2020)
An ErbB2 splice variant lacking exon 16 drives lung carcinoma
Smith HW, Yang L, Ling C, Walsh A, Martinez VD, Boucher J, Zuo D, Sokol ES, Pavlick DC, Frampton GM, Chmielecki J, Jones LM, Roux PP, Lockwood WW, Muller WJ
Proc. Natl Acad. Sci. USA 1, 202007474 (2020)
SPIN90 associates with mDia1 and the Arp2/3 complex to regulate cortical actin organization
Cao L, Yonis A, Vaghela M, Barriga EH, Chugh P, Smith MB, Maufront J, Lavoie G, Meant A, Ferber E, Bovellan M, Alberts A, Bertin A, Mayor R, Paluch EK, Roux PP, Jegou A, Romet-Lemonne G, Charras G
Nature Cell Biol. 22, 803-814 (2020)
NF45 and NF90 regulate mitotic gene expression by competing with Staufen-mediated mRNA decay
Nourreddine S, Lavoie G, Paradis J, Ben El Kadhi K, Meant A, Aubert L, Grondin B, Gendron P, Chabot B, Bouvier M, Carreno S, Roux PP
Cell Reports 31, 107660 (2020)
Controversies around the function of LARP1
Berman AJ*, Thoreen CC*, Dedeic Z, Chettle J, Roux PP*, Blagden SP*
RNA Biol. 1, 1-11 (2020)
F-Actin interactome reveals Vimentin as a key regulator of Actin organization and cell mechanics in mitosis
Serres MP, Samwer M, Truong Quang BA, Petronczki M, Roux PP*, Paluch EK*
Dev. Cell 52, 210-222 (2020)
Loss of DP1 aggravates vascular remodeling in pulmonary arterial hypertension via mTORC1 signaling
He Y, Zuo C, Jia D, Bai P, Kong D, Chen D, Liu G, Li J, Wang Y, Chen G, Yan S, Xiao B, Zhang J, Piao L, Li Y, Deng Y, Li B, Roux PP, Andreasson KI, Breyer RM, Su Y, Wang J, Lyu A, Shen Y, Yu Y
Am. J. Respir. Crit. Care Med. 1, 1-15 (2020)
Proteomic analysis reveals a role for RSK in p120-catenin phosphorylation and melanoma cell-cell adhesion
Meant A, Gao B, Lavoie G, Nourreddine S, Jung F, Aubert L, Tcherkezian J, Gingras AC, Roux PP
Mol. Cell. Proteomics 19, 50-64 (2020)
Disciplines
- Biochemistry
- Cell Biology
- Genetics
Areas of expertise
- Cell Signaling and Cancer
- Genomics
- Metabolism
- Cancer Genetics
- Host-Tumour Interaction
- Cell Therapy of Cancer
- Oncogenes
- Proteomics